SMS Pharmaceuticals Ltd Share Price & Stock Analysis

SMS Pharmaceuticals Ltd (NSE: SMSPHARMA, BSE: 532815) is a Hyderabad, Telangana-based company in the Pharmaceuticals industry. With a market capitalisation of ₹4,903 Cr, it ranks #842 by market cap among the 6,197 Indian listed companies on FinBizNet, and #17 of 63 in Pharmaceuticals. At ₹508.50 (as of 16 Nov 2026), the share price is 5.0% below its 52-week high of ₹535.00 and 88.3% above its 52-week low of ₹270.10. The share price is up 75.6% over one year and up 39.1% over three months.

Key Metrics

Current Price₹508.50
Market Cap₹4,903 Cr
NSE SymbolSMSPHARMA
BSE Code532815
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio47.1
Return on Equity14.31%
Return on Assets6.65%
52-Week Range₹270.10 – ₹535.00
1-Year Price Change+75.6%
3-Month Price Change+39.1%
Beta (1Y)0.51
Dividend Yield0.08%
HeadquartersHyderabad, Telangana
Websitewww.smslife.in

Latest Quarterly Results — Q2 FY27

Revenue₹316 Cr
Net Profit₹40 Cr
Net Margin12.6%
EPS (Basic)₹4.26
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

SMS Pharmaceuticals Ltd Quarterly Revenue and Profit Trend

SMS Pharmaceuticals Ltd reported revenue of ₹316 Cr in Q2 FY27, up 30.4% from ₹242 Cr in Q2 FY26 and up 52.7% from ₹207 Cr in Q1 FY27. It posted a net profit of ₹40 Cr for the quarter, against a net profit of ₹25 Cr in Q2 FY26 (up 57.4%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹196 Cr (Q1 FY26) to ₹316 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹316 Cr₹40 Cr12.6%
Q1 FY27₹207 Cr₹21 Cr10.1%
Q4 FY26₹238 Cr₹33 Cr13.7%
Q3 FY26₹210 Cr₹23 Cr11.2%
Q2 FY26₹242 Cr₹25 Cr10.4%
Q1 FY26₹196 Cr₹20 Cr10.5%
Q4 FY25₹248 Cr₹20 Cr8.2%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 68.07% of SMS Pharmaceuticals Ltd's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 39.2% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About SMS Pharmaceuticals Ltd

Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products. It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025. Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.

Products and Services

1. Pharmaceutical-This segment researches, develops, manufactures, buys, imports, sells, and exports active pharmaceutical ingredients and its intermediates.

SMS Pharmaceuticals Ltd vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
SMS Pharmaceuticals Ltd₹4,903 Cr47.114.31%₹316 Cr+75.6%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of SMS Pharmaceuticals Ltd?

SMS Pharmaceuticals Ltd is trading at ₹508.50, with a market capitalisation of ₹4,903 Cr.

Which sector does SMS Pharmaceuticals Ltd belong to?

SMS Pharmaceuticals Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of SMS Pharmaceuticals Ltd?

SMS Pharmaceuticals Ltd has a P/E of 47.1 and a return on equity of 14.31%.

What is the stock symbol of SMS Pharmaceuticals Ltd?

SMS Pharmaceuticals Ltd is listed on the NSE under the symbol SMSPHARMA and on the BSE under the scrip code 532815.

How has SMS Pharmaceuticals Ltd's share price moved over the past year?

SMS Pharmaceuticals Ltd's share price is up 75.6% over one year and up 39.1% over three months. Its 52-week range is ₹270.10 to ₹535.00.

What were SMS Pharmaceuticals Ltd's latest quarterly results?

In Q2 FY27, SMS Pharmaceuticals Ltd reported revenue of ₹316 Cr and net profit of ₹40 Cr, with basic EPS of ₹4.26 (consolidated, parsed from the company's exchange filing).

How have SMS Pharmaceuticals Ltd's revenue and profit changed over the past year?

SMS Pharmaceuticals Ltd reported revenue of ₹316 Cr in Q2 FY27, up 30.4% from ₹242 Cr in Q2 FY26 and up 52.7% from ₹207 Cr in Q1 FY27.

What is the promoter holding in SMS Pharmaceuticals Ltd?

Promoters held 68.07% of SMS Pharmaceuticals Ltd's shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.